home / stock / rnaz / rnaz articles


RNAZ Articles, TransCode Therapeutics Inc. - From 09/27/23

Stock Information

Company Name: TransCode Therapeutics Inc.
Stock Symbol: RNAZ
Market: NASDAQ
Website: transcodetherapeutics.com

Menu

RNAZ RNAZ Quote RNAZ Short RNAZ News RNAZ Articles RNAZ Message Board
Get RNAZ Alerts

News, Short Squeeze, Breakout and More Instantly...

Why Sharps Technology Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session | Benzinga

Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares jumped 152.8% to $1.09. The company announced the effective date for its reverse stock split after ...

Nasdaq Down 1.5%; Immunovant Shares Spike Higher | Benzinga

U.S. stocks traded lower toward the end of trading, with the Dow Jones falling more than 400 points on Tuesday. The Dow traded down 1.19% to 33,601...

Why TD SYNNEX Shares Are Trading Lower By Over 5%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session | Benzinga

Gainers Soleno Therapeutics, Inc. (NASDAQ: SLNO) shares jumped 318.5% to $18.54 after the company released top-line results from randomized withd...

Crude Oil Moves Higher; Cintas Earnings Top Estimates | Benzinga

U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling more than 1% on Tuesday. The Dow traded down 0.96% to 33,681.79 ...

Why Transcode Therapeutics (RNAZ) Stock Is Down Nearly 70% | Benzinga

Transcode Therapeutics Inc (NASDAQ: RNAZ) shares are trading lower by 69% to $0.79 Tuesday morning after the company priced its $8 million pub...

Dow Tumbles 150 Points; US House Prices Rise in July | Benzinga

U.S. stocks traded lower this morning, with the Dow Jones falling around 150 points on Tuesday. Following the market opening Tuesday, the Dow trade...

Why Femasys Shares Are Trading Higher By Over 200%; Here Are 20 Stocks Moving Premarket | Benzinga

Gainers Femasys Inc. (NASDAQ: FEMY) shares rose 201% to $1.00 in pre-market trading after the company received FDA 510(k) clearance for FemaSeed, ...

TransCode Therapeutics Announces Pricing of $8 Million Public Offering | Benzinga

BOSTON, Sept. 25, 2023 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (NASDAQ:RNAZ), (the "Company"), an RNA oncology company committed to mor...

Gold Moves Lower; TransCode Therapeutics Shares Surge | Benzinga

U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite trading higher by around 30 points on Monday. The Dow traded down 0.0...

Why Brainstorm Cell Therapeutics Shares Are Trading Lower By 33%? Here Are Other Stocks Moving In Monday's Mid-Day Session | Benzinga

Gainers TransCode Therapeutics, Inc. (NASDAQ: RNAZ) shares jumped 308% to $2.71 after the company announced pre-clinical gliblastoma results with ...

Previous 10 Next 10